Cargando…

Was Pharmaunternehmen neben Corona beflügelt

Detalles Bibliográficos
Autor principal: Mausbach, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Fachmedien Wiesbaden 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794603/
http://dx.doi.org/10.1007/s35128-021-1018-7
_version_ 1784640849921966080
author Mausbach, Carmen
author_facet Mausbach, Carmen
author_sort Mausbach, Carmen
collection PubMed
description
format Online
Article
Text
id pubmed-8794603
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Fachmedien Wiesbaden
record_format MEDLINE/PubMed
spelling pubmed-87946032022-01-28 Was Pharmaunternehmen neben Corona beflügelt Mausbach, Carmen Versicher Mag Invest Springer Fachmedien Wiesbaden 2022-01-28 2022 /pmc/articles/PMC8794603/ http://dx.doi.org/10.1007/s35128-021-1018-7 Text en © Springer Fachmedien Wiesbaden GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Invest
Mausbach, Carmen
Was Pharmaunternehmen neben Corona beflügelt
title Was Pharmaunternehmen neben Corona beflügelt
title_full Was Pharmaunternehmen neben Corona beflügelt
title_fullStr Was Pharmaunternehmen neben Corona beflügelt
title_full_unstemmed Was Pharmaunternehmen neben Corona beflügelt
title_short Was Pharmaunternehmen neben Corona beflügelt
title_sort was pharmaunternehmen neben corona beflügelt
topic Invest
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794603/
http://dx.doi.org/10.1007/s35128-021-1018-7
work_keys_str_mv AT mausbachcarmen waspharmaunternehmennebencoronabeflugelt